KLOW is a four-component research blend of KPV, GHK-Cu, BPC-157, and TB-500 totaling 80 mg. It is listed so laboratories that already work with those four compounds can keep a combined catalog item. Individual listings remain available separately when in stock.
This listing is for laboratory research only. It is not a medicine and this page does not provide dosing or administration guidance. Photography and lot documentation are still being prepared, so the vial cannot be purchased yet.
Laboratory specifications
| Catalog name | KLOW |
|---|---|
| Type | Four-component lyophilized research blend |
| Components | KPV / GHK-Cu / BPC-157 / TB-500 |
| Available amount | 80 mg vial (combined mass) |
| Form | Lyophilized powder |
| Intended use | Laboratory research only |
| Lyophilized storage | Keep frozen, desiccated, and protected from light until use |
| After reconstitution | Typical research handling is 2–8°C, about 30 days, no repeated freeze–thaw cycles |
Component ratios will be stated on the vial label and in lot documentation when published. This page does not describe a combined protocol or any outcome in living systems.
Match any published report to the lot printed on the vial before bench use. Product photos are not a substitute for lot-specific documentation.
